Loading...

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE

Aim. To estimate an effect of metabolic corrector mildronate on cardiac hemodynamics and endothelium function in patients with ischemic heart disease (IHD) and heart failure (HF)Material and methods. 60 patients with IHD and HF of I-III functional class according to NYHA were included into the study...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: I. V. Sergienko, M. E. Bugriy, T. V. Balahonova, G. A. Tkachev, V. B. Sergienko
Format: Artigo
Sprog:Inglês
Udgivet: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Serier:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Fag:
Online adgang:https://www.rpcardio.com/jour/article/view/497
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!